Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
- Zirabev
Descriptions
Bevacizumab-bvzr injection is used together with other cancer medicines to treat patients with metastatic (cancer that has spread) carcinoma of the colon or rectum.
Bevacizumab-bvzr injection is also used to treat nonsquamous, non-small cell lung cancer (NSCLC) that has spread, come back, or cannot be removed by surgery. It is also used to treat a type of brain tumor called glioblastoma that keeps coming back (recurrent).
Bevacizumab-bvzr injection is also used together with other medicines (eg, interferon alfa) to treat patients with metastatic kidney cancer. It is also used in combination with other medicines (eg, paclitaxel and cisplatin, or paclitaxel and topotecan) to treat patients with cervical cancer that is continuing, keeps coming back, or has spread to other parts of the body.
Bevacizumab-bvzr injection is also used in combination with other medicines (eg, paclitaxel, pegylated liposomal doxorubicin, topotecan, carboplatin and paclitaxel, or carboplatin and gemcitabine followed by Zirabev™ alone) to treat patients with platinum-resistant, platinum-sensitive, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer with or without having previous surgery or who have received 2 previous treatments.
Bevacizumab is an antineoplastic that helps the body fight cancer. It prevents the growth of certain types of blood vessels to cancer cells. This helps to decrease the growth of cancer cells by starving the cells of nutrients that are needed to grow.
This medicine is to be given only by or under the immediate supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.